SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 76 filers reported holding SCPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,713,904 | -24.8% | 2,207,009 | +7.6% | 7.44% | -12.8% |
| Q2 2023 | $20,907,893 | +11.0% | 2,051,805 | -1.2% | 8.53% | +23.0% |
| Q1 2023 | $18,827,478 | +3.0% | 2,075,797 | -18.6% | 6.94% | +15.2% |
| Q4 2022 | $18,285,178 | +270.4% | 2,550,234 | +236.9% | 6.02% | +292.7% |
| Q3 2022 | $4,936,000 | -24.0% | 757,063 | -43.8% | 1.53% | -10.2% |
| Q2 2022 | $6,491,000 | -18.2% | 1,346,724 | -3.6% | 1.71% | -12.2% |
| Q1 2022 | $7,933,000 | +15.1% | 1,396,724 | +1.7% | 1.95% | -7.4% |
| Q4 2021 | $6,893,000 | -16.0% | 1,373,124 | +11.3% | 2.10% | +21.8% |
| Q3 2021 | $8,207,000 | +109.1% | 1,234,121 | +92.2% | 1.73% | +144.5% |
| Q2 2021 | $3,924,000 | -31.0% | 642,154 | -24.9% | 0.71% | -41.0% |
| Q1 2021 | $5,686,000 | +68.6% | 855,142 | +34.2% | 1.20% | -12.7% |
| Q4 2020 | $3,372,000 | – | 637,322 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |